1. Prognostic Significance of Interim PET/CT in the First-Line Treatment of Follicular Lymphoma Patients, a Single-Center Experience.
- Author
-
Kiss, Evelin, Simon, Zsófia, Illés, Árpád, and Jóna, Ádám
- Subjects
- *
NON-Hodgkin's lymphoma , *RESEARCH funding , *POSITRON emission tomography computed tomography , *DESCRIPTIVE statistics , *MULTIVARIATE analysis , *RETROSPECTIVE studies , *KAPLAN-Meier estimator , *LOG-rank test , *STATISTICS , *DATA analysis software - Abstract
Simple Summary: Our research looks at a special type of scan, called a PET/CT scan, taken midway through treatment for a blood cancer called follicular lymphoma. Doctors want to know whether this mid-treatment scan can predict how well patients will do in the long run. The study found that patients with a "positive" mid-treatment scan, meaning their cancer is still active, tend to have worse outcomes. This is important because it could help doctors identify high-risk patients early on and potentially adjust their treatment. While other studies have looked at this, this research adds to the evidence and suggests that this mid-treatment scan could be a valuable tool for managing follicular lymphoma. However, more research is needed to confirm these findings and figure out the best way to use this information to improve patient care. Introduction: Follicular lymphoma (FL) is a heterogeneous disease, and identifying high-risk patients early is crucial for optimal management. This study aimed to evaluate the prognostic significance of interim positron emission tomography/computed tomography (PET/CT) in newly diagnosed FL patients undergoing first-line treatment. Methods: This single-center, retrospective study included 103 patients with newly diagnosed FL who underwent interim PET/CT. The primary endpoint was progression-free survival (PFS). The prognostic value of positive interim PET/CT, Deauville scores, and maximum standardized uptake values (SUVmax) were analyzed among other clinical features. Results: A total of 30 patients (29.1%) were deemed interim PET/CT-positive. The interim PET/CT-positive group demonstrated a significantly shorter median PFS compared to the interim PET/CT-negative group (17 months vs. not reached, respectively; p < 0.0001). Similarly, patients with Deauville scores of 1–3 had better PFS, with median survival not yet reached, while those with higher Deauville scores exhibited poorer progression-free survival and a median survival of 18 months. Notably, patients with an interim PET/CT SUVmax exceeding 3.365 experienced significantly shorter median survival compared to those with lower values. Discussion: Our findings support the use of interim PET/CT as a prognostic tool in FL. These results are consistent with other studies, although some debate exists regarding the optimal PET/CT metric. Further research is needed to validate these findings and explore personalized treatment strategies based on interim PET/CT results. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF